Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program

BACKGROUND: The incidence of Merkel cell carcinoma (MCC), a rare form of skin cancer with a poor prognosis, has increased in Italy in recent decades. Avelumab, an anti-programmed death ligand 1 monoclonal antibody, is approved for the treatment of metastatic MCC (mMCC) based on the results of the ph...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Transl Med
Main Authors: Grignani, Giovanni, Chiarion Sileni, Vanna, Pinto, Carmine, Depenni, Roberta, Fazio, Nicola, Galli, Luca, Giuffrida, Dario, Carnaghi, Carlo, Ciliberto, Domenico, Corsi, Domenico C., Queirolo, Paola, Benincasa, Elena, Venturini, Filippo, Fazzi, Gennaro, Costa, Nuno, Ascierto, Paolo Antonio
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2021
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885451/
https://ncbi.nlm.nih.gov/pubmed/33588870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02730-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker